Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

Compass Point is adopting a bullish stance on Nebius Group . The firm initiated the artificial intelligence infrastructure stock with a buy rating and price target of $150, implying upside of 54%.

As it publishes its annual report, Parkland Center for Clinical Innovation has 14 AI models in production with many more ...

Today, Compass updated investors on its drug trial progress, and the stock shot higher. Compass announced two Phase 3 trials ...

Approximately $1.0 million is earned through proof-of-concept completion, $6.0 million across scaled deployment and operational validation, and $3.0 million upon final delivery and full program ...